Option Care (OPCH) Q2 Revenue Jumps 15%
Option Care Health (NASDAQ:OPCH), the leading U.S. provider of home and alternate site infusion services, reported its second-quarter 2025 results on July 30, 2025. The company reported GAAP revenue and non-GAAP earnings ahead of analyst expectations for Q2 2025, as GAAP net revenue climbed 15.4% year-over-year to $1,416.1 million in Q2 2025, outpacing the $1,350.4 million GAAP consensus. Adjusted diluted EPS reached $0.41, a 10.8% gain over Q2 2024 and $0.03 above the $0.38 estimate. While revenue momentum and integration of recent acquisitions fueled top-line growth, Option Care’s GAAP gross profit margin slipped in Q2 2025 and its Cash from operations was significantly lower year-over-year in the second quarter of 2025. Overall, the quarter showed strong sales expansion, balanced by margin pressures and subdued cash generation.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
The company delivers infusion and complex pharmaceutical services outside of hospitals, primarily to patients in their homes, infusion suites, and clinical settings. The company operates with over 8,000 employees, including more than 5,000 clinicians. This network enables broad access for patients requiring chronic and acute infusion therapies for conditions like immune disorders and infections.
Source Fool.com
